CONGRESS|#EHA2021|Philip Moreau highlighted the use of new treatment approaches in clinical practice in MM. Treatment preferences for pts, refractory to lenlidomide after 1st, 2nd or 3rd relapse were also discussed #mmsm, #myeloma, CHU Hotel-Dieu, France pic.twitter.com/v12E2UthG7
— Multiple Myeloma Hub (@MM_Hub) June 11, 2021